메뉴 건너뛰기




Volumn 6, Issue 2, 2005, Pages 76-82

Efficacy of low-dose alteplase for treatment of hemodialysis catheter occlusions

Author keywords

Alteplase; Central venous catheters; Hemodialysis

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; CATHFLO; CLOPIDOGREL; HEPARIN; WARFARIN;

EID: 22944478640     PISSN: 11297298     EISSN: None     Source Type: Journal    
DOI: 10.1177/112972980500600206     Document Type: Article
Times cited : (30)

References (17)
  • 1
    • 14844295975 scopus 로고    scopus 로고
    • Improving arteriovenous fistula construction: Fistula first initiative
    • Besarab A, Brouwer D. Improving arteriovenous fistula construction: fistula first initiative. Hemodialysis Int 2004; 8: 199-206.
    • (2004) Hemodialysis Int. , vol.8 , pp. 199-206
    • Besarab, A.1    Brouwer, D.2
  • 2
    • 0028833101 scopus 로고
    • Are clinical signs accurate indicators of the cause of central venous catheter occlusion?
    • Stephens L, Haire W, Kotulak G. Are clinical signs accurate indicators of the cause of central venous catheter occlusion? JPEN 1995; 19: 75-9.
    • (1995) JPEN , vol.19 , pp. 75-79
    • Stephens, L.1    Haire, W.2    Kotulak, G.3
  • 3
    • 0012373123 scopus 로고    scopus 로고
    • Vascular access for hemodialysis
    • Daugirdas JT, Blake PG, Ing RS, eds. 3rd edition. Philadelphia: Lippincott Williams & Wilkins
    • Besarab A, Raja RM. Vascular access for hemodialysis. In: Daugirdas JT, Blake PG, Ing RS, eds. Handbook of dialysis, 3rd edition. Philadelphia: Lippincott Williams & Wilkins 2001; 67-101.
    • (2001) Handbook of Dialysis , pp. 67-101
    • Besarab, A.1    Raja, R.M.2
  • 4
    • 0036684535 scopus 로고    scopus 로고
    • Alteplase versus urokinase in restoring blood flow in hemodialysis-catheter thrombosis
    • Eyrich H, Walton T, Macon E, Howe A. Alteplase versus urokinase in restoring blood flow in hemodialysis-catheter thrombosis. Am J Health-Syst Pharm 2002; 59: 1437-40.
    • (2002) Am. J. Health-Syst Pharm. , vol.59 , pp. 1437-1440
    • Eyrich, H.1    Walton, T.2    Macon, E.3    Howe, A.4
  • 5
    • 0035149994 scopus 로고    scopus 로고
    • K/DOQI clinical practice guidelines for vascular access
    • National Kidney Foundation. 2000
    • National Kidney Foundation. K/DOQI clinical practice guidelines for vascular access 2000. Am J Kidney Dis 2001; 37 (suppl 1): S139-81.
    • (2001) Am. J. Kidney Dis. , vol.37 , Issue.SUPPL. 1
  • 6
    • 0034209664 scopus 로고    scopus 로고
    • Activity and dosage of alteplase dilution for clearing occlusions of venous-access devices
    • Davis S, Vermeulen L, Banton J, Schwartz B, Williams E. Activity and dosage of alteplase dilution for clearing occlusions of venous-access devices, Am J Health-Sys Pharm 2000; 57: 1039-45.
    • (2000) Am. J. Health-Sys Pharm , vol.57 , pp. 1039-1045
    • Davis, S.1    Vermeulen, L.2    Banton, J.3    Schwartz, B.4    Williams, E.5
  • 7
    • 0035523074 scopus 로고    scopus 로고
    • Catheter thrombosis
    • Beathard G. Catheter thrombosis. Semin Dial 2001; 14: 144-5.
    • (2001) Semin Dial , vol.14 , pp. 144-145
    • Beathard, G.1
  • 8
    • 0036534305 scopus 로고    scopus 로고
    • Safe and cost effective use of alteplase for the clearance of occluded central venous access devices
    • Timoney J, Malkin M, Leone D, et al. Safe and cost effective use of alteplase for the clearance of occluded central venous access devices. J Clin.Oncol 2002; 20: 1918-22.
    • (2002) J Clin.Oncol , vol.20 , pp. 1918-1922
    • Timoney, J.1    Malkin, M.2    Leone, D.3
  • 9
    • 0027258712 scopus 로고
    • Use of tissue plasminogen activator for reopening of clotted dialysis catheters
    • Paulsen D, Reisoether A, Aasen M, Fauchald P. Use of tissue plasminogen activator for reopening of clotted dialysis catheters. Nephron 1993; 64: 468-70.
    • (1993) Nephron , vol.64 , pp. 468-470
    • Paulsen, D.1    Reisoether, A.2    Aasen, M.3    Fauchald, P.4
  • 10
    • 0035187268 scopus 로고    scopus 로고
    • Low-dose tPA for hemodialysis catheter clearance
    • Spry L, Miller G. Low-dose tPA for hemodialysis catheter clearance. Dial Transplant 2001; 30: 10-3.
    • (2001) Dial Transplant , vol.30 , pp. 10-13
    • Spry, L.1    Miller, G.2
  • 11
    • 0034877251 scopus 로고    scopus 로고
    • Recombinant tissue plasminogen activator (Alteplase) for restoration of flow in occluded central venous access devices: A double-blind placebo-controlled trial - The cardiovascular thrombolytic to open occluded lines (COOL) efficacy trial
    • Ponec D, Irwin D, Haire W, et al. Recombinant tissue plasminogen activator (Alteplase) for restoration of flow in occluded central venous access devices: a double-blind placebo-controlled trial - the cardiovascular thrombolytic to open occluded lines (COOL) efficacy trial. J Vasc Interv Radiol 2001; 12: 951-5.
    • (2001) J. Vasc. Interv. Radiol. , vol.12 , pp. 951-955
    • Ponec, D.1    Irwin, D.2    Haire, W.3
  • 12
    • 0034921944 scopus 로고    scopus 로고
    • Thrombolysis for restoration of patency to haemodialysis central venous catheters: A systematic review
    • Clase C, Crowther M, Ingram A, Cina C. Thrombolysis for restoration of patency to haemodialysis central venous catheters: a systematic review. J Thromb Thrombolysis 2001; 11: 127-36.
    • (2001) J. Thromb. Thrombolysis , vol.11 , pp. 127-136
    • Clase, C.1    Crowther, M.2    Ingram, A.3    Cina, C.4
  • 13
    • 1642534357 scopus 로고    scopus 로고
    • Alteplase for central catheter clearance: 1 mg/mL versus 2 mg/2 mL
    • Fink J, Capozzi D, Shermock K, et al. Alteplase for central catheter clearance: 1 mg/mL versus 2 mg/2 mL. Ann Pharmacother 2004; 38: 351-2.
    • (2004) Ann. Pharmacother. , vol.38 , pp. 351-352
    • Fink, J.1    Capozzi, D.2    Shermock, K.3
  • 15
    • 21644472484 scopus 로고    scopus 로고
    • Short and long alteplase dwells in dysfunctional hemodialysis catheters
    • MacRae JM, Loh G, Djurdjeb O, et al. Short and long alteplase dwells in dysfunctional hemodialysis catheters. Hemodialysis Int 2005; 9: 189-95.
    • (2005) Hemodialysis Int. , vol.9 , pp. 189-195
    • MacRae, J.M.1    Loh, G.2    Djurdjeb, O.3
  • 16
    • 8344245223 scopus 로고    scopus 로고
    • Establishing an alteplase dosing protocol for hemodialysis-catheter thrombosis
    • Nguyen T, Dikun M. Establishing an alteplase dosing protocol for hemodialysis-catheter thrombosis. Am J Health-Syst Pharm 2004; 61: 1922-4.
    • (2004) Am. J. Health-Syst Pharm. , vol.61 , pp. 1922-1924
    • Nguyen, T.1    Dikun, M.2
  • 17
    • 0036141026 scopus 로고    scopus 로고
    • A longitudinal study of the repeated use of alteplase as therapy for tunnelled hemodialysis catheter dysfunction 17
    • Little M, Walshe J. A longitudinal study of the repeated use of alteplase as therapy for tunnelled hemodialysis catheter dysfunction. Am J Kidney Dis 2002; 39: 1-15.
    • (2002) Am. J. Kidney Dis. , vol.39 , pp. 1-15
    • Little, M.1    Walshe, J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.